BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25163001)

  • 1. Unnatural amino acids in novel antibody conjugates.
    Hallam TJ; Smider VV
    Future Med Chem; 2014 Jul; 6(11):1309-24. PubMed ID: 25163001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody conjugates with unnatural amino acids.
    Hallam TJ; Wold E; Wahl A; Smider VV
    Mol Pharm; 2015 Jun; 12(6):1848-62. PubMed ID: 25898256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.
    Zimmerman ES; Heibeck TH; Gill A; Li X; Murray CJ; Madlansacay MR; Tran C; Uter NT; Yin G; Rivers PJ; Yam AY; Wang WD; Steiner AR; Bajad SU; Penta K; Yang W; Hallam TJ; Thanos CD; Sato AK
    Bioconjug Chem; 2014 Feb; 25(2):351-61. PubMed ID: 24437342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Switchable Site-Specific Antibody Conjugate.
    Lyu Z; Kang L; Buuh ZY; Jiang D; McGuth JC; Du J; Wissler HL; Cai W; Wang RE
    ACS Chem Biol; 2018 Apr; 13(4):958-964. PubMed ID: 29461804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status: Site-Specific Antibody Drug Conjugates.
    Schumacher D; Hackenberger CP; Leonhardt H; Helma J
    J Clin Immunol; 2016 May; 36 Suppl 1():100-7. PubMed ID: 27003914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.
    McCombs JR; Owen SC
    AAPS J; 2015 Mar; 17(2):339-51. PubMed ID: 25604608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating permissive site-specific unnatural aminoacyl-tRNA synthetases.
    Miyake-Stoner SJ; Refakis CA; Hammill JT; Lusic H; Hazen JL; Deiters A; Mehl RA
    Biochemistry; 2010 Mar; 49(8):1667-77. PubMed ID: 20082521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
    Ross PL; Wolfe JL
    J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to Make Homogenous Antibody Drug Conjugates.
    Kline T; Steiner AR; Penta K; Sato AK; Hallam TJ; Yin G
    Pharm Res; 2015 Nov; 32(11):3480-93. PubMed ID: 25511917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acidic scaffolds bearing unnatural side chains: an old idea generates new and versatile tools for the life sciences.
    Stevenazzi A; Marchini M; Sandrone G; Vergani B; Lattanzio M
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5349-56. PubMed ID: 25455481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing Solid-Phase to Enable High-Throughput, Site-Specific Conjugation and Dual-Labeled Antibody and Fab Conjugates.
    Puthenveetil S
    Methods Mol Biol; 2020; 2078():99-112. PubMed ID: 31643052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing immunoconjugates for cancer therapy.
    Govindan SV; Goldenberg DM
    Expert Opin Biol Ther; 2012 Jul; 12(7):873-90. PubMed ID: 22679911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins.
    Zhou Q
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free unnatural amino acid incorporation with alternative energy systems and linear expression templates.
    Shrestha P; Smith MT; Bundy BC
    N Biotechnol; 2014 Jan; 31(1):28-34. PubMed ID: 24103470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high yielding expression platform for the introduction of non-natural amino acids in protein sequences.
    Roy G; Reier J; Garcia A; Martin T; Rice M; Wang J; Prophet M; Christie R; Dall'Acqua W; Ahuja S; Bowen MA; Marelli M
    MAbs; 2020; 12(1):1684749. PubMed ID: 31775561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal α-amino group modification of antibodies using a site-selective click chemistry method.
    Li DZ; Han BN; Wei R; Yao GY; Chen Z; Liu J; Poon TCW; Su W; Zhu Z; Dimitrov DS; Zhao Q
    MAbs; 2018 Jul; 10(5):712-719. PubMed ID: 29652547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-Specific Antibody Conjugation for ADC and Beyond.
    Zhou Q
    Biomedicines; 2017 Nov; 5(4):. PubMed ID: 29120405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates.
    Strop P; Liu SH; Dorywalska M; Delaria K; Dushin RG; Tran TT; Ho WH; Farias S; Casas MG; Abdiche Y; Zhou D; Chandrasekaran R; Samain C; Loo C; Rossi A; Rickert M; Krimm S; Wong T; Chin SM; Yu J; Dilley J; Chaparro-Riggers J; Filzen GF; O'Donnell CJ; Wang F; Myers JS; Pons J; Shelton DL; Rajpal A
    Chem Biol; 2013 Feb; 20(2):161-7. PubMed ID: 23438745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.